Strong Iodine Solution
RxNorm 204913· STRONG IODINE SOLUTION· ORAL
Safecor Health, LLC
Indications and usage
INDICATIONS Strong Iodine Solution, containing 5 percent of iodine and 10 percent of potassium iodide, is employed in the prophylaxis of simple and colloid goiters and in the treatment of exophthalmic goiter. It can be used alone as a preoperative preparation but is now most commonly used concomitantly with propylthiouracil and other antithyroid drugs. When used with these drugs, Strong Iodine Solution produces involution of the hyperplastic gland thus making a less triable and vascular gland for thyroidectomy. In addition, it has an additive antithyroid action that helps make the patient enthyroid faster than if the antithyroid drugs were used alone.
Dosage and administration
DOSAGE Strong Iodine Solution is for oral use only. The usual dosage of Strong Iodine Solution is 2 to 6 drops (0.1 to 0.3 ml) three times daily taken in water after meals for two or three weeks prior to operation. In thyroid crisis the dosage is 1 ml three times a day.
Warnings
WARNINGS Prolonged therapy may cause iodism. USE IN PREGNANCY: The drug readily crosses the placental barrier and may affect the fetus if used during pregnancy.
Contraindications
CONTRAINDICATIONS The use of iodides may be contraindicated in patients with tuberculosis because it is believed they may cause a breakdown of healing lesions. The use of iodides is contraindicated in patients with iododerma, laryngeal edema, and swelling of salivary glands or increased salivation upon previous exposure to iodides. Strong Iodine Solution is ineffective in the treatment of postoperative thyroid crisis.
Adverse reactions (label)
ADVERSE REACTIONS Ingestion of large quantities of Strong Iodine Solution may cause abdominal pain, nausea, vomiting and diarrhea. Average doses may cause skin rash.
KR · 한국Products in Korea (15)
- 파마치과용요오드글리세린액(주)한국파마
- 휴온스요오드화칼륨정(주)휴온스
- 휴온스요오드화칼륨정(주)휴온스
- 휴온스요오드화칼륨정(주)휴온스
- 휴온스요오드화칼륨정(주)휴온스
- 휴온스요오드화칼륨정(주)휴온스
- 크리렌점안액대우제약(주)
- 유니렌점안액유니메드제약(주)
- 치오단정(요오드화칼륨)한국유나이티드제약(주)
- 치오단정(요오드화칼륨)한국유나이티드제약(주)
- 치오단정(요오드화칼륨)한국유나이티드제약(주)
- 치오단정32.5밀리그램(요오드화칼륨)한국유나이티드제약(주)
- 치오단정32.5밀리그램(요오드화칼륨)한국유나이티드제약(주)
- 치오단정32.5밀리그램(요오드화칼륨)한국유나이티드제약(주)
- 비트레오렌트점안액한불바이오(주)
View more: Full FDA label on DailyMed →Label effective 20250108